Anticardiolipin and/or anti-β2-glycoprotein-I antibodies are associated with adverse IVF outcomes [PDF]
Frontiers in Immunology, 2022 ObjectiveThe purpose of the study is to evaluate the effects of anticardiolipin (aCL) and/or anti-β2-glycoprotein-I (aβ2GPI) antibodies, namely antiphospholipid antibodies (aPL), on in vitro fertilization (IVF) outcomes.Materials and methodsThe study ...
Li Wu +6 more
doaj +4 more sources
Changes in the Level of Antiphospholipid Antibodies (Anticardiolipin and Anti-β2-Glycoprotein-I) and Thromboembolic Indices in COVID-19 Patients during 3 Weeks [PDF]
International Journal of Preventive Medicine, 2023 Introduction: COVID-19 is a respiratory disease caused by infection with severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2). Thrombotic complications appear to be of particular importance in patients with COVID-19.
Somayeh Haghighipour +5 more
doaj +2 more sources
Influence of anticardiolipin and anti‐β2 glycoprotein I antibody cutoff values on antiphospholipid syndrome classification [PDF]
Research and Practice in Thrombosis and Haemostasis, 2019 Background Anticardiolipin (aCL) and anti‐β2 glycoprotein I (aβ2GPI) immunoglobulin (Ig) G/IgM antibodies are 2 of the 3 laboratory criteria for classification of antiphospholipid syndrome (APS).
Laura Vanoverschelde +4 more
doaj +2 more sources
IgA anti-β2-glycoprotein I as an independent risk factor in acute venous thromboembolism [PDF]
Frontiers in ImmunologyBackgroundVenous thromboembolism (VTE) is the third most common cause of cardiovascular death. Primary Antiphospholipid Syndrome (P-APS) is a chronic systemic autoimmune disorder characterized by thrombotic events and/or obstetric complications in ...
Raquel Diaz-Simon +34 more
doaj +2 more sources
Italian Olfactory Identification Test in Systemic Lupus Erythematosus: Association of Olfactory Impairment With Chronic Damage and Anti–β2‐Glycoprotein I Antibodies [PDF]
ACR Open RheumatologyObjective Olfactory dysfunction is a relatively frequent manifestation in systemic lupus erythematosus (SLE). The Italian Olfactory Identification Test (IOIT) may represent a suitable tool for detecting olfactory impairment in patients with SLE, due to ...
Marta Di Berardino +11 more
doaj +2 more sources
Annular leukocytoclastic vasculitis associated with isolated anti-β2 glycoprotein I immunoglobulin G positivity: A case report [PDF]
SAGE Open Medical Case ReportsVasculitis comprises a spectrum of disorders defined inflammation of the blood vessel walls and is categorized based on vessel size into small-, medium-, and large-vessel vasculitis. The histological characteristics of leukocytoclastic vasculitis include
Saleha Abdulrahman Aldawsari +3 more
doaj +2 more sources
IgA Anti-β2-Glycoprotein I Antibodies as Markers of Thrombosis and Severity in COVID-19 Patients [PDF]
VirusesPatients with COVID-19 may develop a hypercoagulable state due to tissue and endothelial injury, produced by an unbalanced immune response. Therefore, an increased number of thromboembolic events has been reported in these patients. The aim of this study
Susana Mellor-Pita +10 more
doaj +2 more sources
Establishment of cutoff values for anti-β2 glycoprotein I antibodies in women of reproductive age in Southwest China [PDF]
Scientific ReportsAntiphospholipid syndrome (APS) is an autoimmune disorder characterized by vascular thrombosis and obstetric morbidity, with accurate laboratory examination of antiphospholipid antibodies (aPLs) being crucial for diagnosis.
Chenxi Liu +8 more
doaj +2 more sources
Isolated IgA Anti-β2 Glycoprotein I Antibodies in Patients with Clinical Criteria for Antiphospholipid Syndrome [PDF]
Journal of Immunology Research, 2014 Seronegative antiphospholipid syndrome (SNAPS) is an autoimmune disease present in patients with clinical manifestations highly suggestive of Antiphospholipid Syndrome (APS) but with persistently negative consensus antiphospholipid antibodies (a-PL). IgA
Raquel Ruiz-García +8 more
doaj +2 more sources
Current Promising Biomarkers and Methods in the Diagnostics of Antiphospholipid Syndrome: A Review
Biomedicines, 2021 Antiphospholipid syndrome (APS) is a hypercoagulation condition associated with the incidence of heterogenic antiphospholipid antibodies (aPLs), which non-specifically affect hemostasis processes.
Pavla Bradacova +8 more
doaj +1 more source